IDT Australia Limited: Strong Final Quarter Pushes Full-Year Revenue Ahead of Guidance

IDT Australia Limited (ASX: IDT) shares an exciting update on its outstanding performance for the three months ending 30th June 2024 (Q4FY24). It announced that the unaudited quarterly revenue had soared unprecedentedly, marking a remarkable 87% increase to AU$4.6 million compared to the previous period (pcp). This impressive growth surpasses its guidance range, with total unaudited revenue for FY24 reaching AU$13.5 million, a staggering 92% rise from the prior year.

The Advanced Therapies pillar witnessed exceptional growth, achieving unaudited revenue of AU$1.1 million compared to AU$0.06 million in the previous corresponding period (pcp). These remarkable results are a testament to IDT's unwavering commitment to growth and success. With this strong foundation, the company is confident in its ability to build on this momentum and continue delivering exceptional value to its stakeholders.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com